Dormant
AAOI · Applied Optoelectronics, Inc.
Last analysed ·
Current thesis
Applied Optoelectronics’ optical-transceiver expansion needs Q3 revenue of at least $255M and a weekly recovery above $110.21 to validate the case. A weekly close below $100 invalidates the recovery thesis.
Kill line
A weekly close below $100 invalidates the recovery thesis at the research threshold retained from the September 3 assessment. Separately, Q3 revenue below the $255M floor guided on August 6 breaks the operating milestone.
Pick status
Open commitment scored if the kill line above fires How this is scored →Latest analysis and events for AAOI —
As of 18 September 2026, the latest FrontierPicks analysis for Applied Optoelectronics, Inc. (AAOI): 14 May 2026: $600M ATM equity distribution via Raymond James/Needham — structural supply ceiling. Track 424B/8-K for actual takedowns; accelerated issuance = management monetizing the mania, a late-cycle tell.
Kill line: A weekly close below $100 invalidates the recovery thesis at the research threshold retained from the September 3 assessment. Separately, Q3 revenue below the $255M floor guided on August 6 breaks the operating milestone.
Current Thesis
Applied Optoelectronics’ optical-transceiver expansion needs Q3 revenue to meet guidance and the shares to recover the lost $110.21 shelf; a weekly close below $100 would invalidate that recovery thesis. The operating test remains the $255M–$290M Q3 revenue guidance issued on 2026-08-06. The 2026-09-11 reference close of $105.36 leaves the market below the shelf lost on 2026-08-28.
The material development since the September 3 assessment is a completed property purchase. A September 10 filing discloses that Applied Optoelectronics paid $26,783,472 in cash on 2026-09-04 for a Houston property containing approximately 153,928 rentable square feet, intended for office, warehouse, light manufacturing and assembly. This establishes a completed capital commitment; the filing provides no incremental production figure. September 10 Form 8-K
The life-cycle assessment remains an inference: the narrative is saturated — the retail-facing coverage cluster on 2026-08-24 and 2026-08-26 was followed by another sector-driven headline on 2026-09-08, but the shares did not retain their recovery above $110.21. The September 8 close was $111.55; the September 9 close was $107.93. This establishes a failed shelf recovery, while the sample is too small to establish persistent changes in investor participation. Historical closes, September 8 coverage
Bullish and bearish views on Applied Optoelectronics, Inc.
The model's bull view on Applied Optoelectronics, Inc. (AAOI), in brief: Revenue already supports the expansion. The 2026-08-06 Q2 results reported $191.922M of revenue, up 86% year over year, and $107.662M of datacenter revenue. These are reported sales supporting the production-ramp thesis; Q3 revenue below the guided $255M floor would contradict… The bear view: Profit guidance trails revenue expectations. Both cases follow in full.
Bull Case
- Revenue already supports the expansion. The 2026-08-06 Q2 results reported $191.922M of revenue, up 86% year over year, and $107.662M of datacenter revenue. These are reported sales supporting the production-ramp thesis; Q3 revenue below the guided $255M floor would contradict its next operating milestone.
- Management has specified the ramp. On the 2026-08-06 earnings call, management targeted approximately 650,000 combined 800G and 1.6T transceivers per month by year-end 2026. These products transmit at 800 gigabits and 1.6 terabits per second. The output target is management guidance, and a disclosed year-end production shortfall would invalidate that capacity milestone.
- Expansion commitments became completed spending. The 2026-09-04 Houston acquisition followed the separate industrial leases signed on 2026-08-31. The purchase provides evidence of continued facility investment, although the September 10 filing does not establish when additional transceiver shipments begin. Acquisition filing, August lease filing
Bear Case
- Profit guidance trails revenue expectations. The 2026-08-06 outlook put Q3 earnings per share, adjusted outside generally accepted accounting principles (non-GAAP), at $0.11–$0.26 against the contemporaneous $0.28 consensus cited in the September 3 assessment. Revenue within guidance accompanied by a non-GAAP gross margin below Q2’s 29.8% would show that higher sales had not preserved profitability.
- Equity capacity remains a supply risk. The 2026-08-21 prospectus authorized up to $600M of at-the-market equity issuance. Authorization does not establish proceeds, and an updated amount actually sold is unavailable in the evidence reviewed. The previous description of the program as undrawn is therefore unsupported.
- Receivables concentrate the cash-conversion test. The Q2 filing reported Digicomm International receivables of $211.0M within total accounts receivable of $314.009M at 2026-06-30, on longer-than-typical terms. A Q3 disclosure showing that customer balance above its June level would confirm that collection exposure had increased.
Setup & Price Structure
The 2026-09-11 adjusted reference close of $105.36 is above the previously identified $104.50 August 24 low and below the $110.21 shelf lost on August 28. The September 8 close above that shelf did not persist through September 9. A weekly close above $110.21 would satisfy the price-repair component of the thesis; a weekly close below $100 would end it. September session history
As of 2026-09-11, the shares were 52.8% below the $223.10 52-week high, with a three-month price change of -37.7% and a 14-day relative strength index of 34.1. Those supplied market measurements describe weakness; they do not establish that a reversal is imminent.
The observable attention evidence is the August 24 offering-coverage cluster, the August 26 retrospective-return article and the September 8 sector-rally article. These publications measure coverage, not ownership concentration. No updated short-interest figure or current moving-average slope is available to support a stronger crowding claim.
Catalyst Calendar (next 30 days)
As of 2026-09-13, the company’s events page lists no upcoming event. The elapsed September 9 estimated Federal Communications Commission (FCC) agenda date is no longer an upcoming catalyst; the agenda’s contents remain unverified, so its passage cannot establish policy failure. Company events calendar
- 2026-09-30 — FCC meeting checkpoint. The FCC schedule cited in the September 3 assessment lists this meeting date. An optical-transceiver proceeding has not been verified. A named docket or published text would substantiate the policy component; a meeting without either would leave that component unconfirmed.
- ~2026-11-05, est. Q3 results. This remains an unconfirmed calendar estimate, outside the next 30 days. The release tests the August 6 revenue guidance of $255M–$290M and whether non-GAAP gross margin preserves Q2’s 29.8%; the company has not posted the earnings date on its events page. Company calendar
What Would Change Our Mind
The recovery thesis breaks if the market loses the retained $100 research threshold on a weekly close below $100. That is the price invalidation carried by the September 3 assessment, rather than a newly established support low. Independently, reported Q3 revenue below the August 6 guidance floor of $255M would invalidate the expected revenue milestone.
For this assessment, the case plays out only if Q3 revenue reaches at least $255M, non-GAAP gross margin reaches at least the Q2 level of 29.8%, and the market records a weekly close above $110.21 before invalidation. These are explicit research conditions, not reported outcomes. The failed September 8 shelf recovery and the absence of a company-announced earnings date keep the probability assessment low.
Correlation Notes
Benzinga attributed the 2026-09-08 advance to an industry rally following a Corning–Verizon optical-fiber supply agreement. That is the publication’s explanation, not evidence of an Applied Optoelectronics customer award. A single sector-linked session is too small a sample to support a stable correlation estimate. September 8 report
This remains a single-company setup: the August 6 revenue guidance and September 4 facility acquisition are its operating evidence. A broader optical-networking rally satisfies none of the Q3 revenue or margin conditions specified above.
Notes
- 2026-04-18: seed: Serenity/attention list
- 2026-05-14: $600M ATM equity distribution via Raymond James/Needham — structural supply ceiling. Track 424B/8-K for actual takedowns; accelerated issuance = management monetizing the mania, a late-cycle tell.
- Two $600,000,000 ATM programs (2026-05-14 and 2026-08-21) sit under one automatic shelf, Form S-3ASR No. 333-283905; remaining May capacity is not disclosed.
- Raymond James & Associates is a sales agent under both ATM programs while its equity research separately publishes ratings and targets on the shares.
- $124.9M of 2.75% convertible senior notes due 2030-01-15 and an Amazon-subsidiary customer warrant sit outside the basic share count.
- Reported beta is 3.69; the Tradr 2X Short AAOI Daily ETF (AAOZ) has traded since 2026-07-15 against a float near 80M shares.
- Sales by the SVP and Asia General Manager run under a 10b5-1 plan adopted 2026-03-19, so individual sale dates are pre-scheduled.
- The 2026-08-18 Rosenblatt conference figures (200,000+ units/month, $200M 1.6T order) were spoken remarks and were not restated in an 8-K.
Related · shared themes
ALAB
Astera Labs, Inc.
Q2 (2026-08-04) answered the July margin question: GM 73.7% vs ~73% guide, and Q3 guided $540–560M vs $416.5M consensus (~40% QoQ) with Scorpio X switches in volume production a quarter early. Price has not confirmed — the 2026-08-14 close of $321.61 is ~11% below the post-print level and 33.4% under the $483.02 52-week high.
CRDO
Credo Technology Group Holding Ltd
Interconnect/AEC royalty narrative still accelerating, not fading — new 52-week highs on late-June initiations (Evercore $325, Stifel $350, BofA $340) plus the early-July AI-buildout rally. But it's now mainstream and widely held, entering a ~6-week catalyst void until the late-Aug Q1 FY27 print with macro tightening; continuation intact, though chasing all-time highs here is lower-edge than a pullback to support.
KEYS
Keysight Technologies, Inc.
Analyst-migration re-rate's second leg (Morgan Stanley to Overweight, PT $400, 2026-07-13) has stalled — silent tape near 28x forward, empty calendar until the ~2026-08-19 Q3 FY26 print. The $290–300 breakout-shelf entry hasn't come; current levels buy the tail. Theme accelerating, the KEYS expression maturing.
KOPN
Kopin Corporation
Kopin Corporation's defense orders and optical-interconnect pivot support a recovery case toward the $6.39 market high recorded as of 2026-09-18. The forecast succeeds if that high is reached by the next quarterly report, estimated for 2026-11-10, before a weekly close below $4.00 invalidates it.